Bruker Q4 Revenues Decline 6 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Bruker reported after the close of the market on Wednesday that its fourth quarter revenues declined 6 percent year over year as currency effects negatively impacted revenues by nearly 8 percent.

For the three months ended Dec. 31, the company reported revenues of $478.2 million, down from $508 million in Q4 2014. The results beat the average analysts' estimate of $470 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.